LEADER 01342nam0-2200409---450 001 990005657840203316 005 20190403124950.0 035 $a000565784 035 $aUSA01000565784 035 $a(ALEPH)000565784USA01 035 $a000565784 100 $a20041112d1985----|||y0itaa50------ba 101 $afre 102 $afr 105 $a0 00||| 200 1 $a<> instrument périodique$ela fonction de la presse au 18. siècle$fClaude Labrosse, Pierre Retat$gavec la collaboration de Henri Duranton$gCentre d'Etudes du 18 siècle de l'Université de Lyon 2 210 $aLyon$cPresses Universitaires de Lyon$dstampa 1985 215 $a178 p.$d22 cm. 606 $aEditoria$xFrancia$xSec. 18.$2F 606 $aPERIODICI FRANCESI$xSEC. 18.$2F 620 $dLYON 676 $a070.5'094 700 1$aLABROSSE,$bClaude$0245627 701 1$aRETAT,$bPierre$0413494 702 1$aDURANTON,$bHenri 801 0$aIT$bSA$c20111219 912 $a990005657840203316 950 0$aDipar.to di Filosofia - Salerno$dDFCC 070.5'094 LAB$e4741 FIL 951 $aCC 070.5'094 LAB$b4741 FIL 959 $aBK 969 $aFIL 979 $c20121027$lUSA01$h1525 979 $c20121027$lUSA01$h1615 979 $aPATRY$b90$c20130305$lUSA01$h1612 996 $aInstrument périodique$9620587 997 $aUNISA NUM $aSA0012116 LEADER 02718nam 2200625 450 001 9910825059003321 005 20230803195546.0 010 $a1-61499-332-7 035 $a(CKB)2670000000546623 035 $a(EBL)1637641 035 $a(SSID)ssj0001211621 035 $a(PQKBManifestationID)11687421 035 $a(PQKBTitleCode)TC0001211621 035 $a(PQKBWorkID)11204395 035 $a(PQKB)10150969 035 $a(Au-PeEL)EBL1637641 035 $a(CaPaEBR)ebr10843827 035 $a(CaONFJC)MIL577339 035 $a(MiAaPQ)EBC1637641 035 $a(OCoLC)871531221 035 $a(EXLCZ)992670000000546623 100 $a20140314h20142014 uy| 0 101 0 $aeng 135 $aur|n||||||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe case of the frozen addicts $ehow the solution of a medical mystery revolutionized the understanding of parkinson's disease /$fby Dr. J. William Langston and Jon Palfreman 210 1$aAmsterdam :$cIOS Press,$d[2014] 210 4$d©2014 215 $a1 online resource (264 p.) 300 $aIncludes index. 311 $a1-61499-331-9 327 $a""Title Page""; ""Contents""; ""Authors' Note""; ""Prologue""; ""Part One""; ""All in the Mind""; ""Drugs by Design""; ""The Forgotten Case""; ""Brain Damage""; ""Research Wars""; ""A New Start for Parkinson's Disease""; ""Starting Over""; ""Fame and Misfortune""; ""Side Effects""; ""The Cause""; ""To Catch a Chemist""; ""Trail of Ironies""; ""New Treatments""; ""Part Two""; ""Mending the Brain""; ""Miracles""; ""Nemesis""; ""Doing the Unthinkable""; ""Embryonic Conflicts""; ""The Long Journey""; ""Out on a Limb""; ""The Turning Point""; ""Going Public""; ""Unending Quest""; ""Epilogue"" 327 $a""Additional material for 2014 edition""""What's New in Parkinson's Disease Research?""; ""Acknowledgments""; ""About the authors""; ""Index"" 606 $aParkinson's disease$vCase studies 606 $aMethylphenyltetrahydropyridine$xPhysiological effect 606 $aDesigner drugs$xToxicology 606 $aFetal tissues$xTransplantation$vCase studies 606 $aParkinson's disease$xAnimal models 615 0$aParkinson's disease 615 0$aMethylphenyltetrahydropyridine$xPhysiological effect. 615 0$aDesigner drugs$xToxicology. 615 0$aFetal tissues$xTransplantation 615 0$aParkinson's disease$xAnimal models. 676 $a616.8/33 700 $aLangston$b J. William$01615588 702 $aPalfreman$b Jon 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910825059003321 996 $aThe case of the frozen addicts$93945864 997 $aUNINA